Approximately 33% of ovarian clear cell carcinoma cases exhibit co-mutations of ARID1A and PIK3CA, which activate pro-inflammatory cytokine genes via the NF-kB pathway, thereby promoting tumor growth. The gene discussed is PIK3CA; the disease is neoplasm.